IE users: please get the latest browser version at Microsoft Internet Explorer Home Page
if yot already have the latest browser version please verify that your browser settings is not in compatibility mode
These multipotent adherent progenitor cells (MultiStem®) are derived from mononuclear bone marrow cells that are depleted of CD45(+)/glycophorin-A (GlyA)(+) cells, using micromagnetic beads.
Cells are grown in CD45−GlyA−cell expansion medium supplemented with EGF (10 ng/mL), PDGF-BB (10 ng/mL) and FBS (18%), on plates coated with fibronectin (10 ng/mL), laminin, or type IV collagen. Expansion medium: low-glucose DMEM (60%), MCDB-201 (40%), insulin (x1) transferrin selenium, linoleic acid, bovine serum albumin (x1), dexamethasone (10−9 M), ascorbic acid 2-phosphate (10−4 M), penicillin (100 U), and streptomycin (1000 U). Once adherent cells are more than 50% confluent, they are detached with trypsin-EDTA (0.25%) and are replated at a 1:4 dilution.